LRM Aesthetics, a wholly owned subsidiary of Lynch Regenerative Medicine, is proud to offer our first product, ariessence pure PDGF+ a cutting-edge topical solution for skin rejuvenation. It offers providers a quick, easy to use, consistent, and trusted approach to post-procedure skin rejuvenation, while giving clients joy and confidence through the appearance of healthier, more vibrant skin. Please visit us at ariessence.com to learn all about our incredible product.
Addressing a $100 billion market opportunity in skin rejuvenation (aesthetics) and regeneration (healing).
Multiple product opportunities in each skin aesthetic and healing indications.
Proven leadership has created over $1 B in value in regenerative medicine space.
Proven, proprietary technology based on the body’s own healing protein already FDA approved in other indications.
Valuations of companies in similar markets trading at 16X revenue.
Compelling growth strategy to minimize risk and maximize return by building core capabilities that serve both aesthetics and healing indications.
A New, Advanced Skin Care Company Poised to Address Major, Underserved Skin Conditions
~ $100+ billion is spent annually today to regenerate and rejuvenate skin
Aesthetics
Markets are vast and largely underserved with differentiated solutions.
$61 billion spent on treatment annually.
Chronic Wounds
6 million US patients
-
Diabetic Ulcers (2.5M)
-
Pressure Ulcers (2.5M)
-
Other (1M+)
$25 billion spent on treatment annually in the US
Acute Wounds
Over 35 million US patients
-
Post Surgical (30M)
-
Trauma (2.5M)
-
Burns (750k)
$11 billion spent on treatment annually in the US
Regenerative Impact
rhPDGF delivered from a needle tip (dark shadow entering from the left side of the video) attracts the patient's regenerative stem cells!
rhPDGF attracts and stimulates YOUR OWN stem cells to power natural skin rejuvenation and regeneration.
rhPDGF may help patients achieve healthier, more attractive and better feeling skin.